Categories: MoU

Cadila Pharmaceuticals Ltd. signs MoU with the Government of Gujarat

Pharma Giant to invest Rs. 1,000 crores in different ongoing projects in phases

Ahmedabad, March 25, 2023: One of the oldest and largest privately held pharma groups in the country, Cadila Pharmaceuticals Ltd., Ahmedabad signed a MoU with the government of Gujarat on Monday to invest Rs. 1,000 crores in different existing projects.

The MoU was signed in Gandhinagar on Monday morning between Industries Commissioner Mr. Rahul Gupta on behalf of the government of Gujarat and Cadila Pharmaceuticals COO Mr. Mitul Dave, under the Government of Gujarat’s “Atma Nirbhar Gujarat Schemes for Assistance to Industries” scheme.

Chief Minister Shri. Bhupendra Patel, Industries Minister Shri. Balvantsingh Rajput, Finance Minister Shri. Kanubhai Desai, and Senior Government officials were present at the MoU signing ceremony. Mr. Biswajit Mitra, Chief Mentoring Officer, Mr Mitul Dave, Chief Operating Officer, and Mr RajPrakash Vyas, President of Corporate Affairs were present from Cadila Pharmaceuticals Ltd.

“We are delighted to sign this MOU with the Gujarat Government. Gujarat is the most preferred investment destination because of its conducive business environment, ease of doing business, and investor-friendly policies. Cadila Pharmaceuticals Ltd. is in expansion mode and therefore investing to upgrade its existing facilities to meet emerging demands. We continue to grow and expand into newer geographies and categories in sync with our commitment to provide affordable medicines to the world,” said Dr. Rajiv Modi, Chairman & Managing Director of Cadila Pharmaceuticals Ltd. 

Cadila Pharmaceuticals Ltd. will overall invest Rs. 1000 crores in a span of three years until 2025 for setting up an Active Pharmaceuticals Ingredients (APIs) plant at Dahej, Bharuch & Ankleshwar and the Formation of Tablet & Capsules at Dholka Dist. Plant.

As Proposed, these plants will create direct and indirect Employment for around 500 people (direct) and 1000 (indirect) respectively by 2025.

As per the MoU, the Government of Gujarat will facilitate Cadila Pharmaceuticals Ltd. to obtain necessary permissions, registrations, approvals and clearances from the concerned departments as per its existing policies and regulations.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

17 hours ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

17 hours ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago